|
||||||||||||
|
Scientific Advisory Board
After hearing that there was nothing anyone could do to help us or save
Brad's life, Brad had a dream that told him to a specific clinical trial
number in a packet he had received. When we looked at that treatment, it
was Monoclonal Antibodies at Duke University. We contacted Dr. Henry
Friedman and he returned our call that night at 11pm. By the following
week, Brad was at Duke having the procedure. It gave him nine months of
tumor free time and a fantastic quality of life. The friends we have
made at Duke in the doctors, nurses etc was unbelievable. "At Duke there
is Hope"! The people at Duke really cared about our family and continued
to provide Brad with "weapons" with which to fight. He tried over 7
different chemotherapies. We truly believe that Duke's Brain Tumor
Center is made up of the people it takes to find the CURE .. We also
would like to recognize the staff at the Department of Neurosurgery at
the University of Pennsylvania. They are wonderful and are taking very
big steps to educate and assist patients and their families. Both Penn
and Duke are integral parts in all our fundraising efforts and we are
truly grateful to have these wonderful human beings working to find a cure.
We are extremely grateful to have worked with UCLA and their Department of Neurosurgery. They are compassionate and committed to finding a cure for brain tumors.
Therefore our Scientific Advisory Board is made up of:
Darell D. Bigner, M.D., Ph.D.
Henry S. Friedman, M.D.
Allan Friedman, M.D.
M. Sean Grady M.D.
Linda M. Liau, M.D., Ph.D.
Research Professor of Pathology The National Institute of Neurologic
Disorders and Stroke Specialized Center of Research (SRC) on Malignant
Human Gliomas, Medulloblastomas, and Metastases to the Central Nervous
System at Duke University Medical Center and is intimately wedded to the
Clinical Program, assuring rapid translation of the most recent and
exciting laboratory discoveries to the clinic.
Professor of Neuro Oncology is an internationally recognized
neuro-oncologist with a career-long interest in the treatment of
children and adults with brain and spinal cord tumors, and has written
hundreds of articles on both the clinical and laboratory investigation
of these neoplasms. He is head of the Pediatric Oncology Group Brain
Tumor Committee and the Laboratory of Medical/Pediatric Neuro-Oncology
at Duke University Medical Center, and is an Associate Chief of the
Preuss Laboratory for Brain Tumor Research.
Chief, Division of Neurosurgery is an internationally recognized tumor
and vascular neurosurgeon. He has a career-long interest in
neuro-oncology, is responsible for over ninety percent of all tumor
resections and biopsies conducted at Duke, and has written hundreds of
articles on the neurosurgical management of brain tumors and vascular
lesions. He is also head of the Laboratory of Neurosurgical Oncology and
an associate chief of the Preuss Laboratory for Brain Tumor Research.
Professor of Neurosurgery Dr. Grady was appointed the Charles Harrison
Frazier Professor & Chairman of the Department of Neurosurgery at the
University of Pennsylvania School of Medicine.
Professor of Neurosurgery. Dr.. Liau is the Director of the UCLA Brain
Tumor Program at the UCLA Department of Neurosurgery & Jonsson
Comprehensive Cancer Center. Dr. Liau and her team are conducting
extensive brain tumor research including translational experimental
therapeutics of cell-based therapies for brain tumors and
characterization of molecular targets involved in brain tumor
pathogenesis and progression. She has published dozens of peer-reviewed
research articles along with several book chapters and a textbook
entitled Brain Tumor Immunotherapy (Humana Press, 2001). She is
Editor-in-Chief of the Journal of Neuro-Oncology.
|
The Brad Kaminsky Foundation for Brain Tumor Research 20227 Catlett Place Ashburn, VA 20147 (703) 729-9897 E-mail DNL1231@aol.com |
|
|
|
![]() ![]() |
![]() |